NASDAQ : LUNG

Pulmonx Corporation — Company profile

Healthcare · Medical Devices · United States

Last price 3.165 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 135.93M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Details

NamePulmonx Corporation
SectorHealthcare
IndustryMedical Devices
Employees296
Founded1995
Ipo Date2020-10-01
CeoGlendon French
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price19.00
IsinUS7458481014
Cusip745848101
Cik0001127537
Sic3841

Key executives

NameTitle
Glendon E. FrenchChief Executive Officer, President and Director
Dr. Derrick Sung Ph.D.Chief Financial Officer and Chief Operating Officer
David A. Lehman J.D.General Counsel and Secretary
Srikanth RadhakrishnanChief Science and Technology Officer
Marcee M. MaroneyVice President of Marketing
Jérôme ErathSenior Vice President and GM of International
Geoffrey Beran RoseChief Commercial Officer
Dr. Narinder S. Shargill Ph.D.Senior Vice President of Global Medical and Clinical Affairs
John B. McKuneVice President of Finance and Corporate Controller

Contact

Address700 Chesapeake Drive, Redwood City, California 94063, United States
Phone650 364 0400
Websitehttps://www.pulmonx.com